Anti‐Inflammatory and Antidiabetic Metabolites From Mitragyna diversifolia : In Vitro, Phytochemical, and Computational Studies
Chemical Biology & Drug Design · 2026
DOI: 10.1111/cbdd.70234 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2026. Verfasst von Jing Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Kunming, China. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Anti-Inflammatory Agents, Phytochemicals. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Yunnan Revitalization Talents Support Plan.
Abstract (Originalsprache)
Mitragyna diversifolia is commonly used to cure diarrhoea in the Bandarban region. However, the impact of anti‐inflammatory properties and underlying material basis remains unexplored. This study aimed to determine the anti‐inflammatory and antidiabetic potential of metabolites from M. diversifolia . The results indicated that 2,4‐di‐tert‐bylphenol ( 8 ), cryptotanshinone ( 9 ), and dihydrotanshinone I ( 10 ) not only effectively inhibited LPS‐induced NO production but also demonstrated potential antidiabetic activities by promoting glucose uptake. Network pharmacological analysis, molecular docking, and molecular dynamics simulation revealed that AKT1 was a crucial target for the anti‐inflammatory and antidiabetic effects of M. diversifolia . At the same time, molecular docking analysis showed that compounds 8 , 9 , and 10 possessed superior binding capacities with AKT1 (−7.3, −11.9, and −11.7 kcal/mol, respectively). Collectively, this study preliminarily clarified the possible material basis and mechanism of M. diversifolia to prevent inflammation and diabetes. Further research is needed to determine the in vivo conditions of compounds 8 , 9 , and 10 , particularly with regard to their safety and efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Kunming, China.
- University of Chinese Academy of Sciences, Beijing, China.
ORCID-Profile: Yumei Zhang
Förderung
- Yunnan Revitalization Talents Support Plan
Zitieren
APA
Lu, J., Wang, H., Zhang, K., Zhao, X., Chen, X., Chen, Y., & Zhang, Y. (2026). Anti‐Inflammatory and Antidiabetic Metabolites From Mitragyna diversifolia : In Vitro, Phytochemical, and Computational Studies. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70234
Vancouver
Lu J, Wang H, Zhang K, Zhao X, Chen X, Chen Y, et al. Anti‐Inflammatory and Antidiabetic Metabolites From Mitragyna diversifolia : In Vitro, Phytochemical, and Computational Studies. Chemical Biology & Drug Design. 2026. doi:10.1111/cbdd.70234
BibTeX
@article{Lu2026,
author = {Lu, Jing and Wang, Hanlei and Zhang, Kun and Zhao, Xia and Chen, Xuelin and Chen, Yuping and Zhang, Yumei},
title = {Anti‐Inflammatory and Antidiabetic Metabolites From Mitragyna diversifolia : In Vitro, Phytochemical, and Computational Studies},
journal = {Chemical Biology & Drug Design},
year = {2026},
doi = {10.1111/cbdd.70234}
}
EUVIMED